Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nisijima

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Clinical Psychopharmacology|February 1, 2000
Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndromeK Nisijima
Biological Psychiatry|January 1, 1993
Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective studyK Nisijima, T Ishiguro
Biological Psychiatry|February 1, 1990
Neuroleptic malignant syndrome: a study of CSF monoamine metabolismK Nisijima, T Ishiguro
The Journal of ECT|June 23, 1999
Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five casesK Nisijima, T Ishiguro
Kokyu to Junkan. Respiration & Circulation|December 1, 1991
[ICU syndrome]K Nisijima, M Hirayama
Journal of Psychiatric Research|May 1, 1995
Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndromeK Nisijima, T Ishiguro
Biological Psychiatry|April 15, 1997
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndromeK Nisijima, M Noguti, T Ishiguro
Neuroradiology|May 1, 1994
Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndromeK Nisijima, M Matoba, T Ishiguro
Psychopharmacology|June 27, 2000
Risperidone counteracts lethality in an animal model of the serotonin syndromeK Nisijima, T Yoshino, T Ishiguro
Acta Psychiatrica Scandinavica|November 20, 1998
Treatment of tardive dystonia with an antispastic agentK Nisijima, M Shimizu, T Ishiguro
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychopharmacology|February 1, 2000
Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndromeK Nisijima
Biological Psychiatry|January 1, 1993
Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective studyK Nisijima, T Ishiguro
Biological Psychiatry|February 1, 1990
Neuroleptic malignant syndrome: a study of CSF monoamine metabolismK Nisijima, T Ishiguro
The Journal of ECT|June 23, 1999
Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five casesK Nisijima, T Ishiguro
Kokyu to Junkan. Respiration & Circulation|December 1, 1991
[ICU syndrome]K Nisijima, M Hirayama
Journal of Psychiatric Research|May 1, 1995
Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndromeK Nisijima, T Ishiguro
Biological Psychiatry|April 15, 1997
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndromeK Nisijima, M Noguti, T Ishiguro
Neuroradiology|May 1, 1994
Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndromeK Nisijima, M Matoba, T Ishiguro
Psychopharmacology|June 27, 2000
Risperidone counteracts lethality in an animal model of the serotonin syndromeK Nisijima, T Yoshino, T Ishiguro
Acta Psychiatrica Scandinavica|November 20, 1998
Treatment of tardive dystonia with an antispastic agentK Nisijima, M Shimizu, T Ishiguro
Pageof 2